Salmon Se
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 5%
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
Papers in
- Oncology 16
- Cancer Treatment and Pharmacology 8
- Cancer Cells and Metastasis 2
-
- Glycosylation and Glycoproteins Research 3
- Co-authors
- Alberts Ds (7 shared papers)Hamburger Aw (5 shared papers)Meyskens Fl (4 shared papers)Von Hoff (2 shared papers)B Soehnlen (3 shared papers)Lai-Sang Young (2 shared papers)Jones Se (3 shared papers)Albert Schilling (1 shared paper)
- Journals
- PubMed (34 papers)
- Partner nations
- United States
In The Last Decade
Salmon Se
34 papers receiving 925 citations
Peers
Comparison fields: 5 of 95
- Hematology 307
- Oncology 438
- Cancer Research 150
- Pharmacology 77
- Reproductive Medicine 69
Countries citing papers authored by Salmon Se
This map shows the geographic impact of Salmon Se's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salmon Se with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salmon Se more than expected).
Fields of papers citing papers by Salmon Se
This network shows the impact of papers produced by Salmon Se. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salmon Se. The network helps show where Salmon Se may publish in the future.
Co-authors
The 23 scholars most cited alongside Salmon Se, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Direct cloning of human ovarian carcinoma cells in agar. | 1978 | 277 |
| 2 | Immunoglobulin synthesis and tumor kinetics of multiple myeloma. | 1973 | 132 |
| 3 | Activity of isotretinoin against squamous cell cancers and preneoplastic lesions. | 1982 | 88 |
| 4 | New drugs in ovarian cancer and malignant melanoma: in vitro phase II screening with the human tumor stem cell assay. | 1981 | 72 |
| 5 | Clinical correlations of in vitro drug sensitivity. | 1980 | 58 |
| 6 | In vitro evaluation of anticancer drugs with the human tumor stem cell assay. | 1981 | 47 |
| 7 | In vitro drug assay: pharmacologic considerations. | 1980 | 43 |
| 8 | Intermittent high-dose prednisone (NSC-10023) therapy for multiple myeloma. | 1967 | 40 |
| 9 | Combination chemotherapy with adriamycin (NSC-123127) and cyclophosphamide (NSC-26271) for solid tumors: a phase II trial. | 1976 | 38 |
| 10 | In vitro clonal assay for human metastatic melanoma cells. | 1981 | 36 |
| 11 | Adriamycin (NSC-123127) in the treatment of alkylator-resistant multiple myeloma: a pilot study. | 1975 | 35 |
| 12 | Use of an image analysis system to count colonies in stem cell assays of human tumors. | 1980 | 34 |
| 13 | Relevance of multidrug resistance to rheumatoid arthritis: development of a new therapeutic hypothesis. | 1996 | 27 |
| 14 | Nitrosoureas in multiple myeloma. | 1976 | 27 |
| 15 | Development of a bioassay for human myeloma colony-forming cells. | 1980 | 17 |
| 16 | Salvage treatment of patients relapsing after breast cancer adjuvant chemotherapy. | 1980 | 16 |
| 17 | A phase I study of therapy with recombinant granulocyte-macrophage colony-stimulating factor administered by IV bolus or continuous infusion. | 1988 | 14 |
| 18 | Morphologic studies of tumor colonies. | 1980 | 12 |
| 19 | Hemopoietic stem cell transplants for multiple myeloma. | 1994 | 12 |
| 20 | Idiotype specific peptides bind to the surface immunoglobulins of two murine B-cell lymphoma lines, inducing signal transduction. | 1995 | 12 |
About Salmon Se
Salmon Se is a scholar working on Oncology, Molecular Biology, Hematology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 34 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Multiple Myeloma Research and Treatments (8 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (3 papers), Ovarian cancer diagnosis and treatment (2 papers), Breast Cancer Treatment Studies (2 papers), Cancer Cells and Metastasis (2 papers) and Cell Image Analysis Techniques (2 papers). The work is most often cited by research in Hematology (307 citations), Oncology (438 citations), Cancer Research (150 citations), Pharmacology (77 citations) and Reproductive Medicine (69 citations). Salmon Se has collaborated with scholars based in United States. Frequent co-authors include Alberts Ds, Hamburger Aw, Meyskens Fl, Von Hoff, B Soehnlen, Lai-Sang Young, Jones Se, Albert Schilling, Emilio Gil‐Martín and Shadduck Rk. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.